INESSS reassessment supports the therapeutic value of SKYCLARYS and advances the reimbursement pathway for eligible patients in Quebec. TORONTO, June 8, 2026 /CNW/ - Biogen Canada Inc. is pleased to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

For people living with Friedreich ataxia (FA), preserving function matters as abilities change over time. Meet three Canadians determined to hold on to what matters most to them. Like many people her ...

Lexeo Therapeutics, Inc. ( LXEO) is strengthening its position in Friedreich ataxia through the planned acquisition of Mantle Therapeutics and the launch of patients living with the rare genetic ...

Virtual-first, multidisciplinary care model delivers care for adults living with ataxias, connecting them to expert neurologist options nationwide. CHICAGO, July 16, 2026 /PRNewswire/ -- Synapticure, ...

A Hartlepool woman living with a rare neurological condition says time is of the essence as she campaigns for access to a ...

People living with the rare genetic disorder, Friedreich’s ataxia, have pleaded with the HSE to urgently allow a potentially life-changing medicine to be made available. Campaigners gathered in Dublin ...

Megan Marx is reflecting on the emotional weight of living with a degenerative neurological condition, writing about grief and acceptance three years after her diagnosis with spinocerebellar ataxia.

The sisters are campaigning for access to a drug that could help prolong their lives and give them more precious years with their children ...

Thought LeadersDr. Lauren MooreChief Scientific OfficerNational Ataxia Foundation (NAF) In this interview, we speak to Dr. Lauren Moore from the National Ataxia Foundation about ataxia and how the NFL ...

TORONTO, June 8, 2026 /CNW/ - Biogen Canada Inc. is pleased to announce a positive outcome from the Institut national d'excellence en santé et en services sociaux (INESSS) re-evaluation of SKYCLARYS™ ...